High-density polymorphisms analysis of 23 candidate genes for association with bone mineral density

Bone

Volumn 47, Issue 5, 2010, Pages 975-981

  Giroux, Sylvie ^a   Elfassihi, Latifa ^a,b,c   Clément, Valérie ^a   Bussières, Johanne ^a   Bureau, Alexandre ^b,d   Cole, David E C ^e,f   Rousseau, François ^a,b,g  

^a LAVAL UNIVERSITY   (Canada)

^b UNIVERSITÉ LAVAL   (Canada)

^c Gouvernement du Quebec   (Canada)

^d CENTRE DE RECHERCHE DE L INSTITUT UNIVERSITAIRE EN SANTÉ MENTALE DE QUÉBEC   (Canada)

^e UNIVERSITY OF TORONTO   (Canada)

^f UNIVERSITY OF TORONTO   (Canada)

^g Centre for the Development   (Canada)

Author keywords

Association; Bone mineral density; CSF3R; Osteoporosis; TagSNPs

Indexed keywords

CALCITONIN GENE RELATED PEPTIDE; CALCITONIN RECEPTOR; CALCIUM; CYTOCHROME P450; ESTROGEN; G PROTEIN COUPLED RECEPTOR; GRANULOCYTE COLONY STIMULATING FACTOR RECEPTOR; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 1 RECEPTOR TYPE II; INTERLEUKIN 4 RECEPTOR ALPHA; KLOTHO PROTEIN; LEUKEMIA INHIBITORY FACTOR RECEPTOR ALPHA; PARATHYROID HORMONE; PARATHYROID HORMONE RECEPTOR 1; SIALOPROTEIN; SOMATOMEDIN BINDING PROTEIN 4; TRANSFORMING GROWTH FACTOR BETA1; VITAMIN D; VITAMIN D BINDING PROTEIN;

ADULT; AGED; ARTICLE; BONE DENSITY; CANADA; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HUMAN; HUMERUS; MOUSE; NONHUMAN; POSTMENOPAUSE; PREMENOPAUSE; SINGLE NUCLEOTIDE POLYMORPHISM; TRABECULAR BONE;

EID: 77957752220     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bone.2010.06.030     Document Type: Article

References (46)

1. Ferrari S., Rizzoli R., Slosman D., Bonjour J.P. Familial resemblance for bone mineral mass is expressed before puberty. J Clin Endocrinol Metab 1998, 83:358-361.
2. Pocock N.A., Eisman J.A., Hopper J.L., Yeates M.G., Sambrook P.N., Eberl S. Genetic determinants of bone mass in adults. A twin study. J Clin Invest 1987, 80:706-710.
3. Smith D.M., Nance W.E., Kang K.W., Christian J.C., Johnston C.C. Genetic factors in determining bone mass. J Clin Invest 1973, 52:2800-2808.
4. Berger C., Langsetmo L., Joseph L., Hanley D.A., Davison K.S., Josse R., et al. Change in bone mineral density as a function of age in women and men and association with the use of antiresorptive agents. CMAJ 2008, 178:1660-1668.
5. Brown L.B., Streeten E.A., Shapiro J.R., McBride D., Shuldiner A.R., Peyser P.A., et al. Genetic and environmental influences on bone mineral density in pre- and post-menopausal women. Osteoporos Int 2005, 16:1849-1856.
6. Ioannidis J.P., Ntzani E.E., Trikalinos T.A., Contopoulos-Ioannidis D.G. Replication validity of genetic association studies. Nat Genet 2001, 29:306-309.
7. Liu Y.Z., Liu Y.J., Recker R.R., Deng H.W. Molecular studies of identification of genes for osteoporosis: the 2002 update. J Endocrinol 2003, 177:147-196.
8. Ioannidis J.P.A. Why most published research findings are false. PLoS Med 2005, 2.
9. Shen H., Liu Y., Liu P., Recker R.R., Deng H.W. Nonreplication in genetic studies of complex diseases-lessons learned from studies of osteoporosis and tentative remedies. J Bone Miner Res 2005, 20:365-376.
10. Giguere Y., Rousseau F. The genetics of osteoporosis: "complexities and difficulties". Clin Genet 2000, 57:161-169.
11. Koller D.L., Ichikawa S., Johnson M.L., Lai D., Xuei X., Edenberg H.J., et al. Contribution of the LRP5 gene to normal variation in peak BMD in women. J Bone Miner Res 2005, 20:75-80.
12. Koay M.A., Woon P.Y., Zhang Y., Miles L.J., Duncan E.L., Ralston S.H., et al. Influence of LRP5 polymorphisms on normal variation in BMD. J Bone Miner Res 2004, 19:1619-1627.
13. Ferrari S.L., Deutsch S., Choudhury U., Chevalley T., Bonjour J.P., Dermitzakis E.T., et al. Polymorphisms in the low-density lipoprotein receptor-related protein 5 (LRP5) gene are associated with variation in vertebral bone mass, vertebral bone size, and stature in whites. Am J Hum Genet 2004, 74:866-875.
14. van Meurs J.B., Rivadeneira F., Jhamai M., Hugens W., Hofman A., van Leeuwen J.P., et al. Common genetic variation of the low-density lipoprotein receptor-related protein 5 and 6 genes determines fracture risk in elderly white men. J Bone Miner Res 2006, 21:141-150.
15. Giroux S., Elfassihi L., Cardinal G., Laflamme N., Rousseau F. LRP5 coding polymorphisms influence the variation of peak bone mass in a normal population of French-Canadian women. Bone 2007, 40:1299-1307.
16. Ezura Y., Nakajima T., Urano T., Sudo Y., Kajita M., Yoshida H., et al. Association of a single-nucleotide variation (A1330V) in the low-density lipoprotein receptor-related protein 5 gene (LRP5) with bone mineral density in adult Japanese women. Bone 2007, 40:997-1005.
17. Saarinen A., Valimaki V.V., Valimaki M.J., Loyttyniemi E., Auro K., Uusen P., et al. The A1330V polymorphism of the low-density lipoprotein receptor-related protein 5 gene (LRP5) associates with low peak bone mass in young healthy men. Bone 2007, 40:1006-1012.
18. Bollerslev J., Wilson S.G., Dick I.M., Islam F.M., Ueland T., Palmer L., et al. LRP5 gene polymorphisms predict bone mass and incident fractures in elderly Australian women. Bone 2005, 36:599-606.
19. Koh J.M., Jung M.H., Hong J.S., Park H.J., Chang J.S., Shin H.D., et al. Association between bone mineral density and LDL receptor-related protein 5 gene polymorphisms in young Korean men. J Korean Med Sci 2004, 19:407-412.
20. van Meurs J.B., Trikalinos T.A., Ralston S.H., Balcells S., Brandi M.L., Brixen K., et al. Large-scale analysis of association between LRP5 and LRP6 variants and osteoporosis. JAMA 2008, 299:1277-1290.
21. Giroux S., Elfassihi L., Cole D.E., Rousseau F. Replication of associations between LRP5 and ESRRA variants and bone density in premenopausal women. Osteoporos Int 2008, 19:1769-1775.
22. Richards J.B., Rivadeneira F., Inouye M., Pastinen T.M., Soranzo N., Wilson S.G., et al. Bone mineral density, osteoporosis, and osteoporotic fractures: a genome-wide association study. Lancet 2008, 371:1505-1512.
23. Richards J.B., Kavvoura F.K., Rivadeneira F., Styrkarsdottir U., Estrada K., Halldorsson B.V., et al. Collaborative meta-analysis: associations of 150 candidate genes with osteoporosis and osteoporotic fracture. Ann Intern Med 2009, 151:528-537.
24. Rivadeneira F., Styrkarsdottir U., Estrada K., Halldorsson B.V., Hsu Y.H., Richards J.B., et al. Twenty bone-mineral-density loci identified by large-scale meta-analysis of genome-wide association studies. Nat Genet 2009, 41:1199-1206.
25. Styrkarsdottir U., Halldorsson B.V., Gretarsdottir S., Gudbjartsson D.F., Walters G.B., Ingvarsson T., et al. Multiple genetic loci for bone mineral density and fractures. N Engl J Med 2008, 358:2355-2365.
26. Lindberg M.K., Moverare S., Eriksson A.L., Skrtic S., Gao H., Dahlman-Wright K., et al. Identification of estrogen-regulated genes of potential importance for the regulation of trabecular bone mineral density. J Bone Miner Res 2002, 17:2183-2195.
27. Tsujikawa H., Kurotaki Y., Fujimori T., Fukuda K., Nabeshima Y. Klotho, a gene related to a syndrome resembling human premature aging, functions in a negative regulatory circuit of vitamin D endocrine system. Mol Endocrinol 2003, 17:2393-2403.
28. Giroux S., Rousseau F. Genes and osteoporosis: time for a change in strategy. Int J Clin Rheumatol 2009, 4:221-233.
29. Dequeker J., Tobing L., Rutten V., Geusens P. Relative risk factors for osteoporotic fracture: a pilot study of the MEDOS questionnaire. Clin Rheumatol 1991, 10:49-53.
30. Jamal S.A., Ridout R., Chase C., Fielding L., Rubin L.A., Hawker G.A. Bone mineral density testing and osteoporosis education improve lifestyle behaviors in premenopausal women: a prospective study. J Bone Miner Res 1999, 14:2143-2149.
31. Rubin L.A., Hawker G.A., Peltekova V.D., Fielding L.J., Ridout R., Cole D.E. Determinants of peak bone mass: clinical and genetic analyses in a young female Canadian cohort. J Bone Miner Res 1999, 14:633-643.
32. Barrett J.C., Fry B., Maller J., Daly M.J. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005, 21:263-265.
33. Pritchard J.K., Stephens M., Donnelly P. Inference of population structure using multilocus genotype data. Genetics 2000, 155:945-959.
34. Benjamini Y., Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc 1995, B57:289-300.
35. Scillitani A., Jang C., Wong B.Y., Hendy G.N., Cole D.E. A functional polymorphism in the PTHR1 promoter region is associated with adult height and BMD measured at the femoral neck in a large cohort of young Caucasian women. Hum Genet 2006, 119:416-421.
36. Vilarino-Guell C., Miles L.J., Duncan E.L., Ralston S.H., Compston J.E., Cooper C., et al. PTHR1 polymorphisms influence BMD variation through effects on the growing skeleton. Calcif Tissue Int 2007, 81:270-278.
37. McGuigan F.E., Macdonald H.M., Bassiti A., Farmer R., Bear S., Stewart A., et al. Large-scale population-based study shows no association between common polymorphisms of the TGFB1 gene and BMD in women. J Bone Miner Res 2007, 22:195-202.
38. Langdahl B.L., Uitterlinden A.G., Ralston S.H., Trikalinos T.A., Balcells S., Brandi M.L., et al. Large-scale analysis of association between polymorphisms in the transforming growth factor beta 1 gene (TGFB1) and osteoporosis: the GENOMOS study. Bone 2008, 42:969-981.
39. Hubacek J.A., Weichetova M., Bohuslavova R., Skodova Z., Stepan J.J., Adamkova V. No associations between genetic polymorphisms of TGF-beta, PAI-1, and COL1A1, and bone mineral density in Caucasian females. Endocr Regul 2006, 40:107-112.
40. Ward A.C. The role of the granulocyte colony-stimulating factor receptor (G-CSF-R) in disease. Front Biosci 2007, 12:608-618.
41. van de Geijn G.J., Aarts L.H., Erkeland S.J., Prasher J.M., Touw I.P. Granulocyte colony-stimulating factor and its receptor in normal hematopoietic cell development and myeloid disease. Rev Physiol Biochem Pharmacol 2003, 149:53-71.
42. Takahashi N., Udagawa N., Akatsu T., Tanaka H., Shionome M., Suda T. Role of colony-stimulating factors in osteoclast development. J Bone Miner Res 1991, 6:977-985.
43. Hirbe A.C., Uluckan O., Morgan E.A., Eagleton M.C., Prior J.L., Piwnica-Worms D., et al. Granulocyte colony-stimulating factor enhances bone tumor growth in mice in an osteoclast-dependent manner. Blood 2007, 109:3424-3431.
44. Sekhar R.V., Culbert S., Hoots W.K., Klein M.J., Zietz H., Vassilopoulou-Sellin R. Severe osteopenia in a young boy with Kostmann's congenital neutropenia treated with granulocyte colony-stimulating factor: suggested therapeutic approach. Pediatrics 2001, 108:E54.
45. Takahashi T., Wada T., Mori M., Kokai Y., Ishii S. Overexpression of the granulocyte colony-stimulating factor gene leads to osteoporosis in mice. Lab Invest 1996, 74:827-834.
46. Horiuchi K., Kimura T., Miyamoto T., Miyamoto K., Akiyama H., Takaishi H., et al. Conditional inactivation of TACE by a Sox9 promoter leads to osteoporosis and increased granulopoiesis via dysregulation of IL-17 and G-CSF. J Immunol 2009, 182:2093-2101.